Self-expandable coated stent after intraluminal treatment of esophageal cancer: a risky procedure? Alfred Maier, MD, Hans Pinter, MD, Gerhard B Friehs, MD, Heiko Renner, MD, Freyja M Smolle-Jüttner, MD The Annals of Thoracic Surgery Volume 67, Issue 3, Pages 781-784 (March 1999) DOI: 10.1016/S0003-4975(98)01258-2
Fig 1 Distal and proximal tumor margins, marked with hypodermic needles (arrows) on the surface of the thorax. The Annals of Thoracic Surgery 1999 67, 781-784DOI: (10.1016/S0003-4975(98)01258-2)
Fig 2 Stent deployment. Large arrow indicates stent that is not fully deployed. The Annals of Thoracic Surgery 1999 67, 781-784DOI: (10.1016/S0003-4975(98)01258-2)
Fig 3 Fully deployed stent. Large arrows indicate proximal and distal stent margins. The Annals of Thoracic Surgery 1999 67, 781-784DOI: (10.1016/S0003-4975(98)01258-2)
Fig 4 Postinterventional fluoroscopy. Large arrow indicates punctum maximum of tumor stenosis. The Annals of Thoracic Surgery 1999 67, 781-784DOI: (10.1016/S0003-4975(98)01258-2)